Figure 6

![Figure 6: In vitro evidence for curcumin nanoformulations inhibiting amyloid-beta aggregation is compiled, comparing efficacy across different nanocarrier platforms.]()

> Source: Umair Shabbir et al. "Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The I." *International journal of molecular sciences*, 2020. PMID: [33375513](https://pubmed.ncbi.nlm.nih.gov/33375513/)

<figure>
  <img src="" alt="In vitro evidence for curcumin nanoformulations inhibiting amyloid-beta aggregation is compiled, comparing efficacy across different nanocarrier platforms." />
  <figcaption>Figure 6. In vitro evidence for curcumin nanoformulations inhibiting amyloid-beta aggregation is compiled, comparing efficacy across different nanocarrier platforms.<br>  Source: Umair Shabbir et al. "Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The I." <em>International journal of molecular sciences</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33375513/">33375513</a></figcaption>
</figure>